Polymerase-1 and transcript release factor (PTRF)/ CAVIN1 and cancer: where we are and what is next
Abstract
Polymerase I and transcript release factor (PTRF, also known as CAVIN1) is a unique molecule that has been ascribed with two very different functions; RNA transcription termination and caveolae formation. The role of CAVIN1 in cancer has recently gained researchers’ attention and to-date, studies have shown that CAVIN1 may play a role in various malignancies. Here, we will summarize the role of CAVIN1 in cancer and discuss the possible future research directions for CAVIN1.
Keywords
Full Text:
PDFReferences
Jansa P, Mason SW, Hoffmann-Rohrer U, Grummt I. Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. The EMBO journal. 1998;17(10):2855-64.
Williams JJ, Palmer TM. Cavin-1: caveolae-dependent signalling and cardiovascular disease. Biochemical Society transactions. 2014;42(2):284-8.
Aboulaich N, Vainonen JP, Stralfors P, Vener AV. Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes. The Biochemical journal. 2004;383(Pt 2):237-48.
Jansa P, Grummt I. Mechanism of transcription termination: PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse. Molecular & general genetics : MGG. 1999;262(3):508-14.
Liu L, Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. The Journal of biological chemistry. 2008;283(7):4314-22.
Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008;132(1):113-24.
Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS genetics. 2010;6(3):e1000874.
Briand N, Dugail I, Le Lay S. Cavin proteins: New players in the caveolae field. Biochimie. 2011;93(1):71-7.
Hansen CG, Bright NA, Howard G, Nichols BJ. SDPR induces membrane curvature and functions in the formation of caveolae. Nature cell biology.
;11(7):807-14.
McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, Hernandez VJ, et al. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. The EMBO journal. 2009;28(8):1001-15.
Tagawa M, Ueyama T, Ogata T, Takehara N, Nakajima N, Isodono K, et al. MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis. American journal of physiology Cell physiology. 2008;295(2):C490-8.
Hasegawa T, Takeuchi A, Miyaishi O, Xiao H, Mao J, Isobe K. PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters. The Biochemical journal. 2000;347 Pt 1:55-9.
Bastiani M, Liu L, Hill MM, Jedrychowski MP, Nixon SJ, Lo HP, et al. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. The Journal of cell biology. 2009;185(7):1259-73.
Aung CS, Hill MM, Bastiani M, Parton RG, Parat MO. PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9. European journal of cell biology. 2011;90(2-3):136-42.
Low JY, Nicholson HD. Emerging role of polymerase-1 and transcript release factor (PTRF/ Cavin-1) in health and disease. Cell and tissue research. 2014;357(3):505-13.
Bai L, Deng X, Li Q, Wang M, An W, Deli A, et al. Down-regulation of the cavin family proteins in breast cancer. Journal of cellular biochemistry. 2012;113(1):322-8.
Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998;4(8):1873-80.
Verma P, Ostermeyer-Fay AG, Brown DA. Caveolin-1 induces formation of membrane tubules that sense actomyosin tension and are inhibited by polymerase I and transcript release factor/cavin-1. Molecular biology of the cell. 2010;21(13):2226-40.
Yi JS, Mun DG, Lee H, Park JS, Lee JW, Lee JS, et al. PTRF/cavin-1 is essential for multidrug resistance in cancer cells. Journal of proteome research. 2013;12(2):605-14.
Gould ML, Williams G, Nicholson HD. Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression. The Prostate. 2010;70(15):1609-21.
Inder KL, Zheng YZ, Davis MJ, Moon H, Loo D, Nguyen H, et al. Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways. Molecular & cellular proteomics : MCP. 2012;11(2):M111 012245.
Moon H, Lee CS, Inder KL, Sharma S, Choi E, Black DM, et al. PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer. Oncogene. 2014;33(27):3561-70.
Meng F, Joshi B, Nabi IR. Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration. PloS one. 2015;10(5):e0126056.
Nassar ZD, Moon H, Duong T, Neo L, Hill MM, Francois M, et al. PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis. Oncotarget. 2013;4(10):1844-55.
Shen J, Behrens C, Wistuba, II, Feng L, Lee JJ, Hong WK, et al. Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry. Cancer research. 2006;66(23):11194-206.
Gamez-Pozo A, Sanchez-Navarro I, Calvo E, Agullo-Ortuno MT, Lopez-Vacas R, Diaz E, et al. PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics. PloS one. 2012;7(3):e33752.
Guha U, Chaerkady R, Marimuthu A, Patterson AS, Kashyap MK, Harsha HC, et al. Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(37):14112-7.
Peng J, Liu HZ, Zhong J, Deng ZF, Tie CR, Rao Q, et al. MicroRNA187 is an independent prognostic factor in lung cancer and promotes lung cancer cell invasion via targeting of PTRF. Oncology reports. 2016;36(5):2609-18.
Cai Y, Ruan J, Yao X, Zhao L, Wang B. MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer. Oncology reports. 2017;37(5):2787-94.
Liu L, Xu HX, Wang WQ, Wu CT, Chen T, Qin Y, et al. Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer. Oncogene. 2014;33(21):2728-36.
Wang F, Zheng Y, Orange M, Yang C, Yang B, Liu J, et al. PTRF suppresses the progression of colorectal cancers. Oncotarget. 2016.
Wang X, Liu T, Bai Y, Liao H, Qiu S, Chang Z, et al. Polymerase I and transcript release factor acts as an essential modulator of glioblastoma chemoresistance. PloS one. 2014;9(4):e93439.
Faggi F, Chiarelli N, Colombi M, Mitola S, Ronca R, Madaro L, et al. Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. Lab Invest. 2015;95(6):585-602.
Huertas-Martinez J, Court F, Rello-Varona S, Herrero-Martin D, Almacellas-Rabaiget O, Sainz-Jaspeado M, et al. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1. Cancer letters. 2017;386:196-207.
Liu L, Brown D, McKee M, Lebrasseur NK, Yang D, Albrecht KH, et al. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell metabolism. 2008;8(4):310-7.
DOI: http://dx.doi.org/10.18103/imr.v3i7.524
Refbacks
- There are currently no refbacks.